SOGROYA sol inj 5 mg/1.5ml stylo pré 1.5 ml
7680690630010
CH-69063
H01AC07
07.03.1.
Reimbursement limitations:
SOGROYA.01
SOGROYA est remboursé pour la substitution de l'hormone de croissance endogène (Growth Hormone, GH) chez …
1 / 3
google
Details
- Product number
- 6906301
- CPT
- -
- Packaging group
- 1.5
- Unit
- ml
- Composition
- somapacitanum 5 mg, histidinum, mannitolum, poloxamerum 188, phenolum, acidum hydrochloridum ad pH, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1.5 ml corresp. natrium max. 0.075 mg.
Articles (1)
Sogroya 5 mg/ 1.5 ml, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1.5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 334.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2024
Authorization holder
Novo Nordisk Pharma AG
8302 Kloten
Authorization information
- Swissmedic authorization number
- 69063
- Drug name
- Sogroya, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- H01AC07
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 26/04/2024
- Authorization expiration date
- 25/04/2029
- IT number
- 07.03.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SOGROYA sol inj 5 mg/1.5ml stylo pré 1.5 ml
- Description (DE)
- SOGROYA Inj Lös 5 mg/1.5ml Fertpen 1.5 ml
- Market launch
- 26/04/2024
- Narcotic (BTM)
- No